Read news on Pharmeasy with our app.
Read more in the app
PharmEasy investor cuts value of its stake drastically, implying new valuation of $456M
PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates
Vanguard slashes Ola valuation by 60%-plus; NB reduces Pharmeasy’s by over 90%
